Skip to main content
. 2021 Jun 19;10(2):481–490. doi: 10.1007/s40119-021-00226-6

Fig. 1.

Fig. 1

Phenotypic categories of patients from Bulgaria and Italy with symptomatic ATTRv Glu89Gln amyloidosis at enrollment in THAOS (data cutoff, January 6, 2020). ATTRv Glu89Gln amyloidosis ATTRv amyloidosis associated with the Glu89Gln variant; THAOS Transthyretin Amyloidosis Outcomes Survey